Cargando…
Are the Cardiorenal Benefits of SGLT2 Inhibitors Due to Inhibition of the Sympathetic Nervous System?
[Figure: see text]
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046535/ https://www.ncbi.nlm.nih.gov/pubmed/32142070 http://dx.doi.org/10.1016/j.jacbts.2020.01.011 |